12,466 Shares in Schrödinger, Inc. (NASDAQ:SDGR) Bought by Captrust Financial Advisors

Captrust Financial Advisors acquired a new stake in Schrödinger, Inc. (NASDAQ:SDGR - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 12,466 shares of the company's stock, valued at approximately $240,000.

Several other institutional investors have also added to or reduced their stakes in the company. Barclays PLC boosted its stake in shares of Schrödinger by 421.6% in the 3rd quarter. Barclays PLC now owns 107,554 shares of the company's stock valued at $1,995,000 after purchasing an additional 86,933 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Schrödinger by 3.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 122,702 shares of the company's stock valued at $2,276,000 after purchasing an additional 4,403 shares during the last quarter. Geneos Wealth Management Inc. boosted its position in Schrödinger by 15.4% in the fourth quarter. Geneos Wealth Management Inc. now owns 59,996 shares of the company's stock valued at $1,157,000 after buying an additional 8,021 shares in the last quarter. KBC Group NV grew its stake in shares of Schrödinger by 73.9% during the fourth quarter. KBC Group NV now owns 4,361 shares of the company's stock worth $84,000 after buying an additional 1,853 shares during the last quarter. Finally, Redwood Wealth Management Group LLC increased its holdings in shares of Schrödinger by 8.4% during the fourth quarter. Redwood Wealth Management Group LLC now owns 14,620 shares of the company's stock worth $283,000 after buying an additional 1,132 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Schrödinger Stock Performance

NASDAQ SDGR traded up $0.66 on Tuesday, hitting $22.06. 112,164 shares of the stock traded hands, compared to its average volume of 1,134,512. The business's fifty day moving average is $22.74 and its two-hundred day moving average is $22.15. Schrödinger, Inc. has a 12 month low of $16.60 and a 12 month high of $28.47. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of -9.43 and a beta of 1.84.

Schrödinger (NASDAQ:SDGR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.81) by ($0.01). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The company had revenue of $59.55 million for the quarter, compared to analysts' expectations of $54.60 million. During the same period last year, the company posted ($0.86) EPS. The business's revenue for the quarter was up 62.7% on a year-over-year basis. Analysts expect that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Geoffrey Craig Porges sold 5,491 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $21.76, for a total transaction of $119,484.16. Following the transaction, the chief financial officer now directly owns 27,544 shares of the company's stock, valued at approximately $599,357.44. This trade represents a 16.62% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Karen Akinsanya sold 16,723 shares of the company's stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $25.09, for a total transaction of $419,580.07. Following the sale, the insider now owns 15,625 shares of the company's stock, valued at approximately $392,031.25. The trade was a 51.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 8.60% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

SDGR has been the subject of a number of research reports. KeyCorp raised their price objective on shares of Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a report on Wednesday, April 16th. Piper Sandler cut their price target on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $32.80.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.